A study found people with coronary artery disease saw improved health outcomes after committing to the workout for 12 weeks.

BioCardia Inc (BCDA) reports significant progress with FDA and Japanese regulatory advancements, alongside effective cost control measures despite financial challenges.

Heart failure has historically been irreversible, but the outcome of a new study suggests that could someday change. At the University of Utah, scientists used a new gene therapy that was shown to ...

A supplement widely promoted for athletic performance may interfere with some of the heart's beneficial adaptations to ...

Sepsis, a life-threatening condition caused by dysregulated host response to infection, remains a major cause of global ...

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...

In a recent study published in the journal Nature, a large team of researchers from the United States (U.S.) used single-cell ribonucleic acid (RNA) sequencing combined with high-resolution ...

Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...

Cardiac cirrhosis refers to a spectrum of liver disorders that dysfunction in the heart can cause. It can occur when issues with blood circulation congest the liver and cause injury. Without healthy ...

A heart PET scan is a noninvasive imaging test that uses a small amount of radiation. It helps doctors understand how the heart functions and whether it is healthy. Cardiac or heart PET scans create ...